APO Research
Talk to an analyst

APO RESEARCH · REPORT

Prostate Specific Antigen

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Prostate Specific Antigen Industry Growth and Trends Forecast to 2032

19 December 202593 pages

Choose your research edition.

Industry ResearchProstate Specific Antigen Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Prostate Specific Antigen Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Prostate Specific Antigen Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prostate Specific Antigen Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Prostate Specific Antigen Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Prostate Specific Antigen market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Prostate Specific Antigen is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Prostate Specific Antigen is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Prostate Specific Antigen is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Prostate Specific Antigen include OncBioMune Pharmaceuticals Inc., Inovio Pharmaceuticals, Inc., GenSpera, Inc., Curevac AG, Bavarian Nordic A/S, Aeterna Zentaris Inc. and Advaxis, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Prostate Specific Antigen market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Prostate Specific Antigen market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Prostate Specific Antigen market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Prostate Specific Antigen.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Prostate Specific Antigen market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Prostate Specific Antigen Market by Company

OncBioMune Pharmaceuticals Inc.

Inovio Pharmaceuticals, Inc.

GenSpera, Inc.

Curevac AG

Bavarian Nordic A/S

Aeterna Zentaris Inc.

Advaxis, Inc.

Prostate Specific Antigen Segment by Type

INO-5150

G-115

AEZS-120

ADXS-PSA

Others

Prostate Specific Antigen Segment by Application

Prostate Cancer

Metastatic Hormone Refractory Prostate Cancer

Others

Prostate Specific Antigen Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prostate Specific Antigen market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prostate Specific Antigen and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prostate Specific Antigen.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Prostate Specific Antigen manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Prostate Specific Antigen in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of INO-5150 Table 2. Major Company of G-115 Table 3. Major Company of AEZS-120 Table 4. Major Company of ADXS-PSA Table 5. Major Company of Others Table 6. Global Prostate Specific Antigen Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Prostate Specific Antigen Sales by Type (2021-2026) & (W Units) Table 8. Global Prostate Specific Antigen Sales Market Share in Volume by Type (2021-2026) Table 9. Global Prostate Specific Antigen Sales by Type (2021-2026) & (US$ Million) Table 10. Global Prostate Specific Antigen Sales Market Share in Value by Type (2021-2026) Table 11. Global Prostate Specific Antigen Price by Type (2021-2026) & (US$/Unit) Table 12. Global Prostate Specific Antigen Sales by Type (2027-2032) & (W Units) Table 13. Global Prostate Specific Antigen Sales Market Share in Volume by Type (2027-2032) Table 14. Global Prostate Specific Antigen Sales by Type (2027-2032) & (US$ Million) Table 15. Global Prostate Specific Antigen Sales Market Share in Value by Type (2027-2032) Table 16. Global Prostate Specific Antigen Price by Type (2027-2032) & (US$/Unit) Table 17. North America Prostate Specific Antigen Sales by Type (2021-2026) & (W Units) Table 18. North America Prostate Specific Antigen Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Prostate Specific Antigen Sales by Type (2021-2026) & (W Units) Table 20. Europe Prostate Specific Antigen Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Prostate Specific Antigen Sales by Type (2021-2026) & (W Units) Table 22. Asia-Pacific Prostate Specific Antigen Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Prostate Specific Antigen Sales by Type (2021-2026) & (W Units) Table 24. Latin America Prostate Specific Antigen Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Prostate Specific Antigen Sales by Type (2021-2026) & (W Units) Table 26. Middle East and Africa Prostate Specific Antigen Sales by Type (2021-2026) & (US$ Million) Table 27. Prostate Specific Antigen Industry Trends Table 28. Prostate Specific Antigen Industry Drivers Table 29. Prostate Specific Antigen Industry Opportunities and Challenges Table 30. Prostate Specific Antigen Industry Restraints Table 31. Global Prostate Specific Antigen Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Prostate Specific Antigen Revenue Market Share by Company (2021-2026) Table 33. Global Prostate Specific Antigen Sales by Company (2021-2026) & (W Units) Table 34. Global Prostate Specific Antigen Sales Share by Company (2021-2026) Table 35. Global Prostate Specific Antigen Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Prostate Specific Antigen Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Prostate Specific Antigen Major Company Production Sites and Headquarters Table 38. Global Prostate Specific Antigen Company, Product Type & Application Table 39. Global Prostate Specific Antigen Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Prostate Specific Antigen by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Prostate Specific Antigen Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Prostate Specific Antigen Sales by Region (2021-2026) & (W Units) Table 44. Global Prostate Specific Antigen Sales Market Share in Volume by Region (2021-2026) Table 45. Global Prostate Specific Antigen Sales by Region (2021-2026) & (US$ Million) Table 46. Global Prostate Specific Antigen Sales Market Share in Value by Region (2021-2026) Table 47. Global Prostate Specific Antigen Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Prostate Specific Antigen Sales by Region (2027-2032) & (W Units) Table 49. Global Prostate Specific Antigen Sales Market Share in Volume by Region (2027-2032) Table 50. Global Prostate Specific Antigen Sales by Region (2027-2032) & (US$ Million) Table 51. Global Prostate Specific Antigen Sales Market Share in Value by Region (2027-2032) Table 52. Global Prostate Specific Antigen Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Prostate Specific Antigen Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Prostate Specific Antigen Sales by Application (2021-2026) & (W Units) Table 55. Global Prostate Specific Antigen Sales Market Share in Volume by Application (2021-2026) Table 56. Global Prostate Specific Antigen Sales by Application (2021-2026) & (US$ Million) Table 57. Global Prostate Specific Antigen Sales Market Share in Value by Application (2021-2026) Table 58. Global Prostate Specific Antigen Price by Application (2021-2026) & (US$/Unit) Table 59. Global Prostate Specific Antigen Sales by Application (2027-2032) & (W Units) Table 60. Global Prostate Specific Antigen Sales Market Share in Volume by Application (2027-2032) Table 61. Global Prostate Specific Antigen Sales by Application (2027-2032) & (US$ Million) Table 62. Global Prostate Specific Antigen Sales Market Share in Value by Application (2027-2032) Table 63. Global Prostate Specific Antigen Price by Application (2027-2032) & (US$/Unit) Table 64. North America Prostate Specific Antigen Sales by Application (2021-2026) & (W Units) Table 65. North America Prostate Specific Antigen Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Prostate Specific Antigen Sales by Application (2021-2026) & (W Units) Table 67. Europe Prostate Specific Antigen Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Prostate Specific Antigen Sales by Application (2021-2026) & (W Units) Table 69. Asia-Pacific Prostate Specific Antigen Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Prostate Specific Antigen Sales by Application (2021-2026) & (W Units) Table 71. Latin America Prostate Specific Antigen Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Prostate Specific Antigen Sales by Application (2021-2026) & (W Units) Table 73. Middle East and Africa Prostate Specific Antigen Sales by Application (2021-2026) & (US$ Million) Table 74. OncBioMune Pharmaceuticals Inc. Company Information Table 75. OncBioMune Pharmaceuticals Inc. Business Overview Table 76. OncBioMune Pharmaceuticals Inc. Prostate Specific Antigen Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. OncBioMune Pharmaceuticals Inc. Prostate Specific Antigen Product Portfolio Table 78. OncBioMune Pharmaceuticals Inc. Recent Development Table 79. Inovio Pharmaceuticals, Inc. Company Information Table 80. Inovio Pharmaceuticals, Inc. Business Overview Table 81. Inovio Pharmaceuticals, Inc. Prostate Specific Antigen Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Inovio Pharmaceuticals, Inc. Prostate Specific Antigen Product Portfolio Table 83. Inovio Pharmaceuticals, Inc. Recent Development Table 84. GenSpera, Inc. Company Information Table 85. GenSpera, Inc. Business Overview Table 86. GenSpera, Inc. Prostate Specific Antigen Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. GenSpera, Inc. Prostate Specific Antigen Product Portfolio Table 88. GenSpera, Inc. Recent Development Table 89. Curevac AG Company Information Table 90. Curevac AG Business Overview Table 91. Curevac AG Prostate Specific Antigen Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Curevac AG Prostate Specific Antigen Product Portfolio Table 93. Curevac AG Recent Development Table 94. Bavarian Nordic A/S Company Information Table 95. Bavarian Nordic A/S Business Overview Table 96. Bavarian Nordic A/S Prostate Specific Antigen Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Bavarian Nordic A/S Prostate Specific Antigen Product Portfolio Table 98. Bavarian Nordic A/S Recent Development Table 99. Aeterna Zentaris Inc. Company Information Table 100. Aeterna Zentaris Inc. Business Overview Table 101. Aeterna Zentaris Inc. Prostate Specific Antigen Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Aeterna Zentaris Inc. Prostate Specific Antigen Product Portfolio Table 103. Aeterna Zentaris Inc. Recent Development Table 104. Advaxis, Inc. Company Information Table 105. Advaxis, Inc. Business Overview Table 106. Advaxis, Inc. Prostate Specific Antigen Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Advaxis, Inc. Prostate Specific Antigen Product Portfolio Table 108. Advaxis, Inc. Recent Development Table 109. North America Prostate Specific Antigen Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 110. North America Prostate Specific Antigen Sales by Country (2021-2026) & (W Units) Table 111. North America Prostate Specific Antigen Sales Market Share by Country (2021-2026) Table 112. North America Prostate Specific Antigen Sales Forecast by Country (2027-2032) & (W Units) Table 113. North America Prostate Specific Antigen Sales Market Share Forecast by Country (2027-2032) Table 114. North America Prostate Specific Antigen Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 115. North America Prostate Specific Antigen Market Size by Country (2021-2026) & (US$ Million) Table 116. North America Prostate Specific Antigen Market Share by Country (2021-2026) Table 117. North America Prostate Specific Antigen Market Size Forecast by Country (2027-2032) & (US$ Million) Table 118. North America Prostate Specific Antigen Market Share Forecast by Country (2027-2032) Table 119. Europe Prostate Specific Antigen Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 120. Europe Prostate Specific Antigen Sales by Country (2021-2026) & (W Units) Table 121. Europe Prostate Specific Antigen Sales Market Share by Country (2021-2026) Table 122. Europe Prostate Specific Antigen Sales Forecast by Country (2027-2032) & (W Units) Table 123. Europe Prostate Specific Antigen Sales Market Share Forecast by Country (2027-2032) Table 124. Europe Prostate Specific Antigen Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 125. Europe Prostate Specific Antigen Market Size by Country (2021-2026) & (US$ Million) Table 126. Europe Prostate Specific Antigen Market Share by Country (2021-2026) Table 127. Europe Prostate Specific Antigen Market Size Forecast by Country (2027-2032) & (US$ Million) Table 128. Europe Prostate Specific Antigen Market Share Forecast by Country (2027-2032) Table 129. Asia-Pacific Prostate Specific Antigen Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 130. Asia-Pacific Prostate Specific Antigen Sales by Country (2021-2026) & (W Units) Table 131. Asia-Pacific Prostate Specific Antigen Sales Market Share by Country (2021-2026) Table 132. Asia-Pacific Prostate Specific Antigen Sales Forecast by Country (2027-2032) & (W Units) Table 133. Asia-Pacific Prostate Specific Antigen Sales Market Share Forecast by Country (2027-2032) Table 134. Asia-Pacific Prostate Specific Antigen Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. Asia-Pacific Prostate Specific Antigen Market Size by Country (2021-2026) & (US$ Million) Table 136. Asia-Pacific Prostate Specific Antigen Market Share by Country (2021-2026) Table 137. Asia-Pacific Prostate Specific Antigen Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. Asia-Pacific Prostate Specific Antigen Market Share Forecast by Country (2027-2032) Table 139. Latin America Prostate Specific Antigen Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 140. Latin America Prostate Specific Antigen Sales by Country (2021-2026) & (W Units) Table 141. Latin America Prostate Specific Antigen Sales Market Share by Country (2021-2026) Table 142. Latin America Prostate Specific Antigen Sales Forecast by Country (2027-2032) & (W Units) Table 143. Latin America Prostate Specific Antigen Sales Market Share Forecast by Country (2027-2032) Table 144. Latin America Prostate Specific Antigen Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Latin America Prostate Specific Antigen Market Size by Country (2021-2026) & (US$ Million) Table 146. Latin America Prostate Specific Antigen Market Share by Country (2021-2026) Table 147. Latin America Prostate Specific Antigen Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Latin America Prostate Specific Antigen Market Share Forecast by Country (2027-2032) Table 149. Middle East and Africa Prostate Specific Antigen Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 150. Middle East and Africa Prostate Specific Antigen Sales by Country (2021-2026) & (W Units) Table 151. Middle East and Africa Prostate Specific Antigen Sales Market Share by Country (2021-2026) Table 152. Middle East and Africa Prostate Specific Antigen Sales Forecast by Country (2027-2032) & (W Units) Table 153. Middle East and Africa Prostate Specific Antigen Sales Market Share Forecast by Country (2027-2032) Table 154. Middle East and Africa Prostate Specific Antigen Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 155. Middle East and Africa Prostate Specific Antigen Market Size by Country (2021-2026) & (US$ Million) Table 156. Middle East and Africa Prostate Specific Antigen Market Share by Country (2021-2026) Table 157. Middle East and Africa Prostate Specific Antigen Market Size Forecast by Country (2027-2032) & (US$ Million) Table 158. Middle East and Africa Prostate Specific Antigen Market Share Forecast by Country (2027-2032) Table 159. Key Raw Materials Table 160. Raw Materials Key Suppliers Table 161. Prostate Specific Antigen Distributors List Table 162. Prostate Specific Antigen Customers List Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources Table 166. Primary Sources List of Figures Figure 1. Prostate Specific Antigen Image Figure 2. Global Prostate Specific Antigen Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prostate Specific Antigen Market Size (2021-2032) & (US$ Million) Figure 4. Global Prostate Specific Antigen Sales (2021-2032) & (W Units) Figure 5. INO-5150 Image Figure 6. Global INO-5150 Sales YoY Growth (2021-2032) & (W Units) Figure 7. G-115 Image Figure 8. Global G-115 Sales YoY Growth (2021-2032) & (W Units) Figure 9. AEZS-120 Image Figure 10. Global AEZS-120 Sales YoY Growth (2021-2032) & (W Units) Figure 11. ADXS-PSA Image Figure 12. Global ADXS-PSA Sales YoY Growth (2021-2032) & (W Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 15. Global Prostate Specific Antigen Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Prostate Specific Antigen Market Share by Type 2025 VS 2032 Figure 17. North America Prostate Specific Antigen Sales Market Share in Volume by Type in 2025 Figure 18. North America Prostate Specific Antigen Sales Market Share in Value by Type in 2025 Figure 19. Europe Prostate Specific Antigen Sales Market Share in Volume by Type in 2025 Figure 20. Europe Prostate Specific Antigen Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Prostate Specific Antigen Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Prostate Specific Antigen Sales Market Share in Value by Type in 2025 Figure 23. Latin America Prostate Specific Antigen Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Prostate Specific Antigen Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Prostate Specific Antigen Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Prostate Specific Antigen Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Prostate Specific Antigen Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Prostate Cancer Image Figure 30. Global Prostate Cancer Sales YoY Growth (2021-2032) & (W Units) Figure 31. Metastatic Hormone Refractory Prostate Cancer Image Figure 32. Global Metastatic Hormone Refractory Prostate Cancer Sales YoY Growth (2021-2032) & (W Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 35. Global Prostate Specific Antigen Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Prostate Specific Antigen Market Share by Application 2025 VS 2032 Figure 37. North America Prostate Specific Antigen Sales Market Share in Volume by Application in 2025 Figure 38. North America Prostate Specific Antigen Sales Market Share in Value by Application in 2025 Figure 39. Europe Prostate Specific Antigen Sales Market Share in Volume by Application in 2025 Figure 40. Europe Prostate Specific Antigen Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Prostate Specific Antigen Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Prostate Specific Antigen Sales Market Share in Value by Application in 2025 Figure 43. Latin America Prostate Specific Antigen Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Prostate Specific Antigen Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Prostate Specific Antigen Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Prostate Specific Antigen Sales Market Share in Value by Application in 2025 Figure 47. North America Prostate Specific Antigen Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 48. North America Prostate Specific Antigen Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Prostate Specific Antigen Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Prostate Specific Antigen Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Prostate Specific Antigen Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. Europe Prostate Specific Antigen Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Prostate Specific Antigen Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Prostate Specific Antigen Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Prostate Specific Antigen Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Asia-Pacific Prostate Specific Antigen Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Prostate Specific Antigen Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Prostate Specific Antigen Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Prostate Specific Antigen Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Latin America Prostate Specific Antigen Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Prostate Specific Antigen Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Prostate Specific Antigen Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Prostate Specific Antigen Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 64. Middle East and Africa Prostate Specific Antigen Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Prostate Specific Antigen Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Prostate Specific Antigen Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Prostate Specific Antigen Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Prostate Specific Antigen Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • INO-5150
  • G-115
  • AEZS-120
  • ADXS-PSA
  • Others
Applications
  • Prostate Cancer
  • Metastatic Hormone Refractory Prostate Cancer
  • Others
Companies covered
  • OncBioMune Pharmaceuticals Inc.
  • Inovio Pharmaceuticals, Inc.
  • GenSpera, Inc.
  • Curevac AG
  • Bavarian Nordic A/S
  • Aeterna Zentaris Inc.
  • Advaxis, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Prostate Specific Antigen Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Prostate Specific Antigen Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Prostate Specific Antigen Market by Type
  6. 1.3.1 INO-5150
  7. 1.3.2 G-115
  8. 1.3.3 AEZS-120
  9. 1.3.4 ADXS-PSA
  10. 1.3.5 Others
  11. 1.4 Global Prostate Specific Antigen Market Size by Type
  12. 1.4.1 Global Prostate Specific Antigen Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Prostate Specific Antigen Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Prostate Specific Antigen Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Prostate Specific Antigen Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Prostate Specific Antigen Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Prostate Specific Antigen Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Prostate Specific Antigen Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Prostate Specific Antigen Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Prostate Specific Antigen Industry Trends
  2. 2.2 Prostate Specific Antigen Industry Drivers
  3. 2.3 Prostate Specific Antigen Industry Opportunities and Challenges
  4. 2.4 Prostate Specific Antigen Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Prostate Specific Antigen Revenue (2021-2026)
  2. 3.2 Global Top Players by Prostate Specific Antigen Sales (2021-2026)
  3. 3.3 Global Top Players by Prostate Specific Antigen Price (2021-2026)
  4. 3.4 Global Prostate Specific Antigen Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Prostate Specific Antigen Major Company Production Sites & Headquarters
  6. 3.6 Global Prostate Specific Antigen Company, Product Type & Application
  7. 3.7 Global Prostate Specific Antigen Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Prostate Specific Antigen Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Prostate Specific Antigen Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Prostate Specific Antigen Tier 1, Tier 2, and Tier 3
4 Prostate Specific Antigen Regional Status and Outlook
  1. 4.1 Global Prostate Specific Antigen Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Prostate Specific Antigen Historic Market Size by Region
  3. 4.2.1 Global Prostate Specific Antigen Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Prostate Specific Antigen Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Prostate Specific Antigen Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Prostate Specific Antigen Forecasted Market Size by Region
  7. 4.3.1 Global Prostate Specific Antigen Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Prostate Specific Antigen Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Prostate Specific Antigen Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Prostate Specific Antigen by Application
  1. 5.1 Prostate Specific Antigen Market by Application
  2. 5.1.1 Prostate Cancer
  3. 5.1.2 Metastatic Hormone Refractory Prostate Cancer
  4. 5.1.3 Others
  5. 5.2 Global Prostate Specific Antigen Market Size by Application
  6. 5.2.1 Global Prostate Specific Antigen Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Prostate Specific Antigen Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Prostate Specific Antigen Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Prostate Specific Antigen Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Prostate Specific Antigen Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Prostate Specific Antigen Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Prostate Specific Antigen Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Prostate Specific Antigen Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 OncBioMune Pharmaceuticals Inc.
  2. 6.1.1 OncBioMune Pharmaceuticals Inc. Company Information
  3. 6.1.2 OncBioMune Pharmaceuticals Inc. Business Overview
  4. 6.1.3 OncBioMune Pharmaceuticals Inc. Prostate Specific Antigen Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 OncBioMune Pharmaceuticals Inc. Prostate Specific Antigen Product Portfolio
  6. 6.1.5 OncBioMune Pharmaceuticals Inc. Recent Developments
  7. 6.2 Inovio Pharmaceuticals, Inc.
  8. 6.2.1 Inovio Pharmaceuticals, Inc. Company Information
  9. 6.2.2 Inovio Pharmaceuticals, Inc. Business Overview
  10. 6.2.3 Inovio Pharmaceuticals, Inc. Prostate Specific Antigen Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Inovio Pharmaceuticals, Inc. Prostate Specific Antigen Product Portfolio
  12. 6.2.5 Inovio Pharmaceuticals, Inc. Recent Developments
  13. 6.3 GenSpera, Inc.
  14. 6.3.1 GenSpera, Inc. Company Information
  15. 6.3.2 GenSpera, Inc. Business Overview
  16. 6.3.3 GenSpera, Inc. Prostate Specific Antigen Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 GenSpera, Inc. Prostate Specific Antigen Product Portfolio
  18. 6.3.5 GenSpera, Inc. Recent Developments
  19. 6.4 Curevac AG
  20. 6.4.1 Curevac AG Company Information
  21. 6.4.2 Curevac AG Business Overview
  22. 6.4.3 Curevac AG Prostate Specific Antigen Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Curevac AG Prostate Specific Antigen Product Portfolio
  24. 6.4.5 Curevac AG Recent Developments
  25. 6.5 Bavarian Nordic A/S
  26. 6.5.1 Bavarian Nordic A/S Company Information
  27. 6.5.2 Bavarian Nordic A/S Business Overview
  28. 6.5.3 Bavarian Nordic A/S Prostate Specific Antigen Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Bavarian Nordic A/S Prostate Specific Antigen Product Portfolio
  30. 6.5.5 Bavarian Nordic A/S Recent Developments
  31. 6.6 Aeterna Zentaris Inc.
  32. 6.6.1 Aeterna Zentaris Inc. Company Information
  33. 6.6.2 Aeterna Zentaris Inc. Business Overview
  34. 6.6.3 Aeterna Zentaris Inc. Prostate Specific Antigen Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Aeterna Zentaris Inc. Prostate Specific Antigen Product Portfolio
  36. 6.6.5 Aeterna Zentaris Inc. Recent Developments
  37. 6.7 Advaxis, Inc.
  38. 6.7.1 Advaxis, Inc. Company Information
  39. 6.7.2 Advaxis, Inc. Business Overview
  40. 6.7.3 Advaxis, Inc. Prostate Specific Antigen Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Advaxis, Inc. Prostate Specific Antigen Product Portfolio
  42. 6.7.5 Advaxis, Inc. Recent Developments
7 North America by Country
  1. 7.1 North America Prostate Specific Antigen Sales by Country
  2. 7.1.1 North America Prostate Specific Antigen Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Prostate Specific Antigen Sales by Country (2021-2026)
  4. 7.1.3 North America Prostate Specific Antigen Sales Forecast by Country (2027-2032)
  5. 7.2 North America Prostate Specific Antigen Market Size by Country
  6. 7.2.1 North America Prostate Specific Antigen Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Prostate Specific Antigen Market Size by Country (2021-2026)
  8. 7.2.3 North America Prostate Specific Antigen Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Prostate Specific Antigen Sales by Country
  2. 8.1.1 Europe Prostate Specific Antigen Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Prostate Specific Antigen Sales by Country (2021-2026)
  4. 8.1.3 Europe Prostate Specific Antigen Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Prostate Specific Antigen Market Size by Country
  6. 8.2.1 Europe Prostate Specific Antigen Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Prostate Specific Antigen Market Size by Country (2021-2026)
  8. 8.2.3 Europe Prostate Specific Antigen Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Prostate Specific Antigen Sales by Country
  2. 9.1.1 Asia-Pacific Prostate Specific Antigen Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Prostate Specific Antigen Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Prostate Specific Antigen Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Prostate Specific Antigen Market Size by Country
  6. 9.2.1 Asia-Pacific Prostate Specific Antigen Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Prostate Specific Antigen Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Prostate Specific Antigen Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Prostate Specific Antigen Sales by Country
  2. 10.1.1 South America Prostate Specific Antigen Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Prostate Specific Antigen Sales by Country (2021-2026)
  4. 10.1.3 South America Prostate Specific Antigen Sales Forecast by Country (2027-2032)
  5. 10.2 South America Prostate Specific Antigen Market Size by Country
  6. 10.2.1 South America Prostate Specific Antigen Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Prostate Specific Antigen Market Size by Country (2021-2026)
  8. 10.2.3 South America Prostate Specific Antigen Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Prostate Specific Antigen Sales by Country
  2. 11.1.1 Middle East and Africa Prostate Specific Antigen Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Prostate Specific Antigen Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Prostate Specific Antigen Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Prostate Specific Antigen Market Size by Country
  6. 11.2.1 Middle East and Africa Prostate Specific Antigen Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Prostate Specific Antigen Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Prostate Specific Antigen Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Prostate Specific Antigen Value Chain Analysis
  2. 12.1.1 Prostate Specific Antigen Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Prostate Specific Antigen Production Mode & Process
  7. 12.2 Prostate Specific Antigen Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Prostate Specific Antigen Distributors
  10. 12.2.3 Prostate Specific Antigen Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst